Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) General Information
Description
A small-molecule enzyme inhibitor developed for treating heparin-induced thrombocytopenia.
Contact Information
Corporate Office
- Frederick, MD
- United States
Corporate Office
- Frederick, MD
- United States
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) FAQs
-
Where is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) headquartered?
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is headquartered in Frederick, MD.
-
What industry is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) in?
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s primary industry is Buildings and Property.
-
Is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) a private or public company?
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is a Private company.
-
What is the current valuation of Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)?
The current valuation of Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is .
-
What is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s current revenue?
The current revenue for Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is .
-
Who are Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s investors?
Veralox Therapeutics has invested in Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland).
-
When was Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) acquired?
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) was acquired on 11-Dec-2025.
-
Who acquired Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)?
Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) was acquired by Cadrenal Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process